LIMINATUS PHARMA INC. TO LAUNCH “AMERICAN BNB STRATEGY” SUBSIDIARY AND TARGET UP TO $500 MILLION FUND FOR BNB INVESTMENT AS PART OF CRYPTO MARKET INITIATIVE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.